Bipolar Disorder News and Research

Latest Bipolar Disorder News and Research

High relapse rates in bipolar disorder confirmed

Results from a naturalistic study show that there is a high risk of relapse among bipolar disorder patients, particularly if their medication is changed or stopped.

9 Apr 2014

Medison Pharma inks agreement with Brainsway for exclusive marketing of Deep TMS system in Israel

Medison Pharma has concluded an agreement with the medical device company Brainsway for exclusive marketing and distribution of the Deep TMS (Transcranial Magnetic Stimulation) system in Israel.

9 Apr 2014

State highlights: State mental hospitals compared to prisons; Johnson & Johnson ruling; Va. hospitals pick new leader

Arkansas Attorney General Dustin McDaniel asked the state Supreme Court on Monday to reconsider its decision tossing out a $1.2 billion judgment against drugmaker Johnson & Johnson, saying justices did "significant harm" to the state and broke from 170 years of precedent.

9 Apr 2014

DNA modifications in blood are directly related to changes in brain tissues, say researchers

Johns Hopkins researchers say they have confirmed suspicions that DNA modifications found in the blood of mice exposed to high levels of stress hormone — and showing signs of anxiety — are directly related to changes found in their brain tissues.

9 Apr 2014

Deutsche Forschungsgemeinschaft to establish 5 new Research Units

Topics Range from Composite Structures to Personnel Decisions to Metastatic Cancer Progression / About Eleven Million Euros in Funding for Three Years

4 Apr 2014

Excessive alcohol use does not alter course of bipolar mood states

Patients with bipolar disorder who consume alcohol do not experience significant changes in their self-reported mood states with increased consumption, show Dutch study findings.

3 Apr 2014

Cognitive deficits in bipolar patients ‘not homogenous’

Patients with bipolar disorder can be separated into three groups based on their cognitive performance, a study suggests.

31 Mar 2014

Forest Laboratories, Richter report positive results from cariprazine Phase IIb trial for bipolar depression

Forest Laboratories, Inc. and Gedeon Richter Plc. today announced positive topline results from a Phase IIb trial evaluating the efficacy and safety of the investigational antipsychotic cariprazine in patients with bipolar depression.

31 Mar 2014

NARSAD grants to fund research into psychiatric illness by 40 mid-career scientists

The Brain & Behavior Research Foundation today announced its 2014 NARSAD Independent Investigator Grants, which will award $4 million in funding to 40 mid-career scientists from 33 institutions in nine countries. Selected by the Foundation's Scientific Council, comprised of 146 leading experts across disciplines in brain and behavior research including two Nobel Prize winners, the grants fund basic research, new technologies and next generation therapies for schizophrenia, major affective disorders, and other serious mental illnesses.

28 Mar 2014

Staging model, biomarker proposed for bipolar disorder

Researchers have proposed a model of early and late staging for patients with bipolar disorder according to functioning, number of episodes, age at onset and the time elapsed since first episode.

27 Mar 2014

EEG findings specific to mood state in bipolar disorder

The electrical activity of the brain differs in patients with bipolar disorder according to whether they are experiencing a manic or depressed phase, research shows.

27 Mar 2014

Bidirectional link between life events and mood episodes

The link between life events and mood episodes in patients with bipolar disorder is bidirectional, with positive and negative life events having different effects, report researchers.

27 Mar 2014

Stem cell research opens doors to potential new treatments for bipolar disorder

What makes a person bipolar, prone to manic highs and deep, depressed lows? Why does bipolar disorder run so strongly in families, even though no single gene is to blame? And why is it so hard to find new treatments for a condition that affects 200 million people worldwide?

26 Mar 2014